查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498733

精準醫療市場中的人工智慧，按技術、按組件、按治療應用和按地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Artificial Intelligence in Precision Medicine Market, By Technology, By Component, By Therapeutic Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年，精準醫療中的人工智慧市場規模為18.542億美元，2024年至2032年複合年成長率為20.10%。

精準醫療市場中的人工智慧-市場動態

慢性病盛行率不斷上升推動市場成長

慢性病，也稱為非傳染性疾病 (NCD)，是一大類醫療疾病，包括呼吸系統疾病、糖尿病、癌症和心血管疾病。它們的持續時間較長、進展緩慢以及對醫療護理和監督的持續需求決定了它們。世界衛生組織 (WHO) 報告稱，全球近 71% 的死亡歸因於慢性病，其中低收入和中等收入國家佔這些死亡人數的 85%，令人震驚。慢性病對人們的生活品質、醫療保健系統、勞動生產力以及個人和家庭的生活品質有重大的負面社會經濟影響。人工智慧使醫療保健產業發生了重大轉變，特別是在機器學習和深度學習領域。人工智慧能夠產生預測模型、處理和分析大量資料集以及識別複雜的模式。隨著人工智慧在精準醫學中的應用，透過探索遺傳組成、疾病易感性和治療結果之間的複雜相互作用，可以實現更精確的診斷和個人化的治療介入。基因組研究是人工智慧在精準醫學中的主要用途之一。此外，只要科技不斷發展，人工智慧在精準醫療中的使用可能會成長。即時監測、穿戴式科技和電子健康記錄整合將共同為人工智慧演算法提供持續的資料流進行評估，從而能夠及時修改治療計劃和進行干預。

精準醫療市場中的人工智慧 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 20.10% 左右的複合年成長率成長

基於技術細分，預計深度學習類別將在 2023 年呈現最大市場佔有率

依組件細分，2023年軟體類別為主導類型

按地區分類，北美是 2023 年的主要收入來源

精準醫療市場中的人工智慧-細分分析：

全球精準醫療市場人工智慧根據技術、組件、治療應用和區域進行細分。

市場依技術分為兩類：機器學習、查詢方法、深度學習、情境感知處理和自然語言處理。深度學習類別主導市場。此細分市場的成長可歸因於其高處理能力、資料中心功能的進步以及自動化流程的能力。現代深度學習演算法現在可以跨時間和模式對來自個體的多個資料集進行整合和建模，從而提高預測準確性和針對特定患者的治療建議。

根據治療應用，市場分為以下幾類：腫瘤學、神經學、心臟病學、呼吸系統和其他。腫瘤學類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。腫瘤學領域的人工智慧（AI）預計將透過促進更快速、更準確的癌症診斷來推動該行業在整個預測期內的成長，從而提高患者收入。預計推動腫瘤學產業發展的主要因素是癌症發生率的上升和醫療基礎設施的擴大。此外，預計醫院設施中的醫生和護士等醫務人員將嚴重短缺，這將增加對技術的需求。

精準醫療市場中的人工智慧-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。

在預測期內，預計北美將在全球精準醫療人工智慧市場中佔據最大佔有率。雅培（Abbott）、達能（Danone）、Targeted Medical Pharma, Inc.、雀巢（Nestle）和美贊臣公司（Mead Johnson & Company, LLC）等主要參與者的策略存在對市場的成長有貢獻。例如，生物模擬先驅 Certara, Inc. 於 2022 年 7 月宣布，將與紀念斯隆凱特琳癌症中心合作兩年，開發新的生物模擬軟體。透過這種合作關係，企業可以創建一個用於 CAR T 細胞治療的生物模擬平台。此外，經過特殊修飾的免疫系統T細胞被用於CAR T細胞療法（也稱為免疫療法），以治療特定形式的血癌。

此外，由於人們支付醫療保健的能力不斷增強以及技術發展的步伐，預計在歐洲，精準醫療市場中的人工智慧將以全球最快的速度擴張。政府不斷採取的措施正在推動區域市場的擴張。為了開發創新的癌症檢測、診斷和治療解決方案（尤其是基於人工智慧的解決方案），創新者和研究人員需要幫助將現實世界的腫瘤學資料轉化為所需的品質和規模。這是歐洲癌症成像計劃的目標。

精準醫療市場中的人工智慧-競爭格局：

英特爾公司、Insilico Medicines、NVIDIA 公司、微軟公司和阿斯特捷利康公司等眾多主要參與者都生產人工智慧產品或推出人工智慧在精準醫療領域的新穎應用。這些公司製定了多種策略來增加其市場佔有率。市場的這些發展包括新產品的推出、合約、大型投資、併購以及與其他組織的合作。在不斷上升的市場環境中發展和生存的一項有吸引力的策略是提供具有成本效益的產品。此外，在預估期間，由於監管機構批准的產品，市場預計將達到顯著水準。

最近的發展：

2024 年 1 月：西門子醫療與印度科學研究所 (IISc) 在班加羅爾成立了西門子醫療計算數據科學 (CDS) 合作實驗室。這是一個結合人工智慧（AI）和精準醫療的突破性計畫。 CDS 合作實驗室致力於開發開源人工智慧工具，專注於神經影像領域的進展。這些將成為自動準確描述神經影像資料中異常發現的關鍵工具。

2023 年 3 月：為了幫助製藥公司、生技公司和其他利害關係人加快藥物發現和精準醫療，Google Cloud 推出了兩種新的基於人工智慧 (Al) 的生命科學解決方案。研究團隊可以藉助標靶和先導物來辨識套件更準確地辨識胺基酸的作用。預計這種方法將改善其服務組合併有助於鞏固其在市場中的地位。

目錄

第1章：精準醫療市場中的人工智慧概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 精準醫療市場中的人工智慧技術片段
    • 精準醫療市場中的人工智慧按組件片段
    • 人工智慧在精準醫療市場片段（依治療應用）
    • 人工智慧在精準醫療市場片段（按國家/地區）
    • 人工智慧在精準醫療市場片段（按地區）
  • 競爭洞察

第 3 章：精準醫療中的人工智慧主要市場趨勢

  • 精準醫療市場促進因素中的人工智慧
    • 市場促進因素的影響分析
  • 人工智慧對精準醫療市場的限制
    • 市場限制影響分析
  • 人工智慧在精準醫療市場機遇
  • 人工智慧在精準醫療市場的未來趨勢

第 4 章：精準醫療產業中的人工智慧研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：精準醫療市場中的人工智慧：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：精準醫療市場格局中的人工智慧

  • 人工智慧在精準醫療市場佔有率分析，2023 年
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：精準醫療市場中的人工智慧 - 按技術分類

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 機器學習
    • 查詢方式
    • 深度學習
    • 情境感知處理
    • 自然語言處理

第 8 章：精準醫療市場中的人工智慧 - 按組成部分

  • 概述
    • 按組成部分分類的細分市場佔有率分析
    • 硬體
    • 軟體
    • 服務

第 9 章：精準醫療市場中的人工智慧 - 按治療應用

  • 概述
    • 按治療應用分類的細分市場佔有率分析
    • 腫瘤學
    • 神經病學
    • 心臟病學
    • 呼吸系統
    • 其他

第 10 章：精準醫療市場中的人工智慧 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 精準醫療中的人工智慧北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按技術）
    • 北美市場規模和預測（按組成部分）
    • 北美市場規模與預測（按治療應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 精準醫療中的人工智慧歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模和預測（按組成部分）
    • 歐洲市場規模與預測（按治療應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 精準醫療中的人工智慧亞太區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按技術）
    • 亞太地區市場規模和預測（按組成部分）
    • 亞太地區市場規模與預測（按治療應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 精準醫療中的人工智慧主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按技術）
    • 拉丁美洲市場規模和預測（按組成部分）
    • 拉丁美洲市場規模與預測（按治療應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 精準醫療中的人工智慧中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按技術）
    • 中東和非洲市場規模及預測（按組成部分）
    • 中東和非洲市場規模及預測（按治療應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章：關鍵供應商分析-精準醫療產業人工智慧

  • 競爭儀表板
  • 公司簡介
    • Intel Corporation
    • Insilico Medicines
    • NVIDIA Corporation
    • Zephyr AI
    • Atomwise Inc
    • Microsoft Corporation
    • AtraZeneca
    • Enlitic Inc.
    • Modernizing machine Inc.
    • BioXcel Therapeutics, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2902

REPORT HIGHLIGHT

Artificial Intelligence in Precision Medicine Market size was valued at USD 1,854.2 Million in 2023, expanding at a CAGR of 20.10% from 2024 to 2032.

Precision medicine has never been the same since artificial intelligence (AI) has made it possible to evaluate enormous volumes of biological, clinical, and lifestyle data to customize medicines and treatments for specific patients. With the use of AI algorithms, precision medicine practitioners can now sift and decipher intricate genetic and molecular data, find patterns, and create individualized predictions regarding a patient's prognosis, likelihood of developing a disease, and reaction to various therapies. Clinical professionals can benefit from AI-powered systems that can forecast probable side effects or problems, make more accurate diagnoses, and choose targeted therapies by integrating data from several sources, including wearables, electronic health records, and genetic sequencing.

Artificial Intelligence in Precision Medicine Market- Market Dynamics

Growing Chronic Diseases Prevalence to Propel Market Growth

Chronic diseases, also known as non-communicable diseases (NCDs), are a broad category of medical ailments that include respiratory disorders, diabetes, cancer, and cardiovascular diseases. Their protracted length, gradual advancement, and constant need for medical care and supervision define them. The World Health Organization (WHO) reports that nearly 71% of deaths worldwide are attributable to chronic diseases, with low- and middle-income nations accounting for an astounding 85% of these deaths. Chronic illnesses have a significant negative socioeconomic impact on people's quality of life, as well as on healthcare systems, workforce productivity, and individual and family quality of life. The healthcare sector has seen a significant transformation due to artificial intelligence, particularly in the areas of machine learning and deep learning. Al is capable of producing predictive models, processing and analyzing enormous datasets, and identifying intricate patterns. With Al's application to precision medicine, more precise diagnoses and individualized therapeutic interventions can be achieved by exploring the complex interactions among genetic composition, illness susceptibility, and treatment outcomes. Genomic research represents one of the major uses of Al in precision medicine. Additionally, the use of Al in precision medicine will probably grow as long as technology keeps developing. Real-time monitoring, wearable technology, and electronic health record integration will all work together to offer Al algorithms a constant stream of data to evaluate, allowing for prompt treatment plan modifications and interventions.

Artificial Intelligence in Precision Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.10% over the forecast period (2024-2032)

Based on technology segmentation, the deep learning category was predicted to show maximum market share in the year 2023

Based on component segmentation, the software category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Artificial Intelligence in Precision Medicine Market- Segmentation Analysis:

The Global Artificial Intelligence in Precision Medicine Market is segmented on the basis of Technology, Component, Therapeutic Application, and Region.

The market is divided into two categories based on technology: Machine Learning, Querying Method, Deep Learning, Context-Aware Processing, and Natural Language Processing. The deep learning category dominates the market. The segment's growth can be attributed to its high processing power, advancements in data center capabilities, and its capacity for automated processes. Modern deep learning algorithms can now integrate and model several data sets from an individual across time and modalities, improving prediction accuracy and therapy recommendations for specific patients.

The market is divided into the following categories based on therapeutic application: Oncology, Neurology, Cardiology, Respiratory, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. Artificial intelligence (AI) in oncology is expected to drive the industry's growth throughout the projected period by facilitating more rapid and accurate cancer diagnosis, which in turn improves patient income. The major factors that are anticipated to drive the oncology industry are the rising incidence of cancer and the expanding medical infrastructure. Additionally, it is anticipated that there will be a serious scarcity of medical staff-such as doctors and nurses-in hospital facilities, which will raise demand for technology.

Artificial Intelligence in Precision Medicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for artificial intelligence in precision medicine. The strategic presence of major players, including Abbott, Danone, Targeted Medical Pharma, Inc., Nestle, and Mead Johnson & Company, LLC, is credited with the market's growth. For instance, the biosimulation pioneer Certara, Inc. announced in July 2022 that it would be working with Memorial Sloan Kettering Cancer Center for two years to develop new biosimulation software. Through this partnership, businesses may create a biosimulation platform for the treatment of CAR T cells. Moreover, immune system T-cells that have undergone a special modification are used in CAR T-cell therapy, also referred to as immunotherapy, to treat specific forms of blood cancer.

In addition, the artificial intelligence in precision medicine market is anticipated to expand at the fastest rate in the world during the projected period in Europe because of the population's increasing ability to pay for healthcare and the pace at which technology is developing. The growing government initiatives are fueling the expansion of the regional market. In order to develop innovative cancer detection, diagnosis, and treatment solutions-especially those based on artificial intelligence-innovators and researchers need assistance translating real-world oncology data on the quality and scale required. This is the goal of the European Cancer Imaging Initiative.

Artificial Intelligence in Precision Medicine Market- Competitive Landscape:

Numerous key players, including Intel Corporation, Insilico Medicines, NVIDIA Corporation, Microsoft Corporation, and AstraZeneca, among others, produce goods or introduce novel applications of AI in precision medicine. These companies have developed several strategies to increase their market share. These developments in the market include the introduction of new products, contracts, large investments, mergers and acquisitions, and partnerships with other organizations. One attractive strategy for growing and surviving in the rising market climate is to offer cost-effective products. Furthermore, during the projected period, the market is expected to reach a notable extent due to the product approvals granted by regulatory authorities.

Recent Developments:

January 2024: The Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory was launched by Siemens Healthineers and the Indian Institute of Science (IISc) in Bangalore. This is a ground-breaking project that combines artificial intelligence (AI) and precision medicine. Committed to developing open-source AI tools, the CDS collaborative laboratory is focused on progressing in the area of neuroimaging. These will be key instruments in automating the accurate delineation of abnormal findings in neuroimaging data.

March 2023: In order to help pharmaceutical businesses, biotech companies, and other stakeholders expedite drug discovery and precision medicine, Google Cloud has introduced two new artificial intelligence (Al)-based life sciences solutions. Research teams can more accurately identify the role of amino acids with the aid of the target & lead identification suite. It is anticipated that this approach will improve its service portfolio and help to solidify its position in the market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Intel Corporation

Insilico Medicines

NVIDIA Corporation

Zephyr AI

Atomwise Inc

Microsoft Corporation

AtraZeneca

Enlitic Inc.

Modernizing machine Inc.

BioXcel Therapeutics, Inc.

Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Machine Learning
  • Querying Method
  • Deep Learning
  • Context-Aware Processing
  • Natural Language Processing

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Hardware
  • Software
  • Service

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Precision Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Precision Medicine Market Snippet by Technology
    • 2.1.2. Artificial Intelligence in Precision Medicine Market Snippet by Component
    • 2.1.3. Artificial Intelligence in Precision Medicine Market Snippet by Therapeutic Application
    • 2.1.4. Artificial Intelligence in Precision Medicine Market Snippet by Country
    • 2.1.5. Artificial Intelligence in Precision Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Precision Medicine Key Market Trends

  • 3.1. Artificial Intelligence in Precision Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Precision Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Precision Medicine Market Opportunities
  • 3.4. Artificial Intelligence in Precision Medicine Market Future Trends

4. Artificial Intelligence in Precision Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Precision Medicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Precision Medicine Market Landscape

  • 6.1. Artificial Intelligence in Precision Medicine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Precision Medicine Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Machine Learning
    • 7.1.3. Querying Method
    • 7.1.4. Deep Learning
    • 7.1.5. Context-Aware Processing
    • 7.1.6. Natural Language Processing

8. Artificial Intelligence in Precision Medicine Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Hardware
    • 8.1.3. Software
    • 8.1.4. Service

9. Artificial Intelligence in Precision Medicine Market - By Therapeutic Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Respiratory
    • 9.1.6. Others

10. Artificial Intelligence in Precision Medicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Artificial Intelligence in Precision Medicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Artificial Intelligence in Precision Medicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Intel Corporation
    • 11.2.2. Insilico Medicines
    • 11.2.3. NVIDIA Corporation
    • 11.2.4. Zephyr AI
    • 11.2.5. Atomwise Inc
    • 11.2.6. Microsoft Corporation
    • 11.2.7. AtraZeneca
    • 11.2.8. Enlitic Inc.
    • 11.2.9. Modernizing machine Inc.
    • 11.2.10. BioXcel Therapeutics, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Artificial Intelligence in Precision Medicine Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Technology 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Component 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Therapeutic Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Application
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Therapeutic Application 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)